van der Meer IM - Search Results

1

Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study.

Oei HH, van der Meer IM, Hofman A, Koudstaal PJ, Stijnen T, Breteler MM, Witteman JC. Oei HH, et al. Among authors: van der meer im. Circulation. 2005 Feb 8;111(5):570-5. doi: 10.1161/01.CIR.0000154553.12214.CD. Circulation. 2005. PMID: 15699277

2

The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study.

van der Meer IM, de Maat MP, Kiliaan AJ, van der Kuip DA, Hofman A, Witteman JC. van der Meer IM, et al. Among authors: van der kuip da. Arch Intern Med. 2003 Jun 9;163(11):1323-8. doi: 10.1001/archinte.163.11.1323. Arch Intern Med. 2003. PMID: 12796068

3

Risk factors for progression of atherosclerosis measured at multiple sites in the arterial tree: the Rotterdam Study.

van der Meer IM, Iglesias del Sol A, Hak AE, Bots ML, Hofman A, Witteman JC. van der Meer IM, et al. Stroke. 2003 Oct;34(10):2374-9. doi: 10.1161/01.STR.0000088643.07108.19. Epub 2003 Aug 28. Stroke. 2003. PMID: 12947155

4

Genetic variability of von Willebrand factor and risk of coronary heart disease: the Rotterdam Study.

van der Meer IM, Brouwers GJ, Bulk S, Leebeek FW, van der Kuip DA, Hofman A, Witteman JC, Gómez García EB. van der Meer IM, et al. Among authors: van der kuip da. Br J Haematol. 2004 Feb;124(3):343-7. doi: 10.1046/j.1365-2141.2003.04776.x. Br J Haematol. 2004. PMID: 14717782 Free article.

5

Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study.

van der Meer IM, Bots ML, Hofman A, del Sol AI, van der Kuip DA, Witteman JC. van der Meer IM, et al. Among authors: van der kuip da. Circulation. 2004 Mar 9;109(9):1089-94. doi: 10.1161/01.CIR.0000120708.59903.1B. Epub 2004 Mar 1. Circulation. 2004. PMID: 14993130

6

Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study.

Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, van der Meer IM, Hofman A, Witteman JC. Geleijnse JM, et al. Among authors: van der meer im. J Nutr. 2004 Nov;134(11):3100-5. doi: 10.1093/jn/134.11.3100. J Nutr. 2004. PMID: 15514282 Free article.

7

Genetic variation in Fcgamma receptor IIa protects against advanced peripheral atherosclerosis. The Rotterdam Study.

van der Meer IM, Witteman JC, Hofman A, Kluft C, de Maat MP. van der Meer IM, et al. Thromb Haemost. 2004 Dec;92(6):1273-6. doi: 10.1160/TH04-05-0268. Thromb Haemost. 2004. PMID: 15583733

8

Lipoprotein-associated phospholipase A2 is associated with risk of dementia.

van Oijen M, van der Meer IM, Hofman A, Witteman JC, Koudstaal PJ, Breteler MM. van Oijen M, et al. Among authors: van der meer im. Ann Neurol. 2006 Jan;59(1):139-44. doi: 10.1002/ana.20721. Ann Neurol. 2006. PMID: 16278861

9

Lipoprotein-associated phospholipase A2 and measures of extracoronary atherosclerosis: the Rotterdam Study.

Kardys I, Oei HH, van der Meer IM, Hofman A, Breteler MM, Witteman JC. Kardys I, et al. Among authors: van der meer im. Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):631-6. doi: 10.1161/01.ATV.0000201289.83256.cf. Epub 2005 Dec 22. Arterioscler Thromb Vasc Biol. 2006. PMID: 16373603

10

Soluble Fas, a mediator of apoptosis, C-reactive protein, and coronary and extracoronary atherosclerosis. The Rotterdam Coronary Calcification Study.

van der Meer IM, Oei HH, Hofman A, Pols HA, de Jong FH, Witteman JC. van der Meer IM, et al. Atherosclerosis. 2006 Dec;189(2):464-9. doi: 10.1016/j.atherosclerosis.2006.01.004. Epub 2006 Feb 8. Atherosclerosis. 2006. PMID: 16466728

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters